In Vitro Activity of New Tetracycline Analogs Omadacycline and Eravacycline against Drug-Resistant Clinical Isolates of Mycobacterium abscessus

In vitro activity of the new β-lactamase inhibitors relebactam and vaborbactam in combination with β-lactams against Mycobacterium abscessus complex clinical isolates

(2019) Amit Kaushik et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Omadacycline for Community-Acquired Bacterial Pneumonia

(2019) Roman Stets et al.   NEW ENGLAND JOURNAL OF MEDICINE

Omadacycline for Acute Bacterial Skin and Skin-Structure Infections

(2019) William O’Riordan et al.   NEW ENGLAND JOURNAL OF MEDICINE

Mycobacterium abscessus and antibiotic resistance: Same as it ever was

(2019) David E Griffith   CLINICAL INFECTIOUS DISEASES

In vitro activities of omadacycline against rapidly growing mycobacteria

(2019) Carolyn Shoen et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Randomized, Double-Blind, Placebo-Controlled Studies of the Safety and Pharmacokinetics of Single and Multiple Ascending Doses of Eravacycline

(2018) Joseph V. Newman et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

IGNITE4: Results of a Phase 3, Randomized, Multicenter, Prospective Trial of Eravacycline vs. Meropenem in the Treatment of Complicated Intra-Abdominal Infections

(2018) Joseph S Solomkin et al.   CLINICAL INFECTIOUS DISEASES

Combinations of avibactam and carbapenems exhibit enhanced potencies against drug-resistant Mycobacterium abscessus

(2017) Amit Kaushik et al.   Future Microbiology

Assessing the Efficacy and Safety of Eravacycline vs Ertapenem in Complicated Intra-abdominal Infections in the Investigating Gram-Negative Infections Treated With Eravacycline (IGNITE 1) Trial

(2017) Joseph Solomkin et al.   JAMA Surgery

Tigecycline Is Highly Efficacious against Mycobacterium abscessus Pulmonary Disease

(2016) Beatriz E. Ferro et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Discovery, pharmacology, and clinical profile of omadacycline, a novel aminomethylcycline antibiotic

(2016) S. Ken Tanaka et al.   BIOORGANIC & MEDICINAL CHEMISTRY

Review of Eravacycline, a Novel Fluorocycline Antibacterial Agent

(2016) George G. Zhanel et al.   DRUGS

US Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosis: executive summary

(2015) R Andres Floto et al.   THORAX

Clinical experience in 52 patients with tigecycline-containing regimens for salvage treatment of Mycobacterium abscessus and Mycobacterium chelonae infections

(2014) R. J. Wallace et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Burden and trends of hospitalisations associated with pulmonary non-tuberculous mycobacterial infections in Germany, 2005–2011

(2013) Felix C Ringshausen et al.   BMC INFECTIOUS DISEASES

Synergistic activities of tigecycline with clarithromycin or amikacin against rapidly growing mycobacteria in Taiwan

(2013) Chien-Wen Huang et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Nontuberculous Mycobacterial Lung Disease Prevalence at Four Integrated Health Care Delivery Systems

(2010) D. Rebecca Prevots et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Clinical Outcome of Mycobacterium abscessus Infection and Antimicrobial Susceptibility Testing

(2010) Yi-Ching Huang et al.   JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION

A Novel Gene, erm(41), Confers Inducible Macrolide Resistance to Clinical Isolates of Mycobacterium abscessus but Is Absent from Mycobacterium chelonae

(2009) K. A. Nash et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY